Publication:
HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behcet's Disease

dc.contributor.authorNAMDAR PEKİNER, FİLİZ MEDİHA
dc.contributor.authorBORAHAN, MEHMET OĞUZ
dc.contributor.authorsPekiner, Filiz Namdar; Aytugar, Emre; Demirel, Gulderen Yanikkaya; Borahan, M. Oguz
dc.date.accessioned2022-03-14T10:53:57Z
dc.date.accessioned2026-01-10T18:49:58Z
dc.date.available2022-03-14T10:53:57Z
dc.date.issued2013
dc.description.abstractObjective: The aims of the present study were to typify the human leukocyte antigen system (HLA)-A, B (class I) and HLA-DR, DQ (class II) antigens and to assess the frequency of the presence of these antigens in the Turkish population with recurrent aphthous ulceration (RAU) and Behcet's disease (BD) compared to healthy subjects. Subjects and Methods: Thirty patients with RAU, 30 with BD, and 15 healthy subjects were included in the study. HLA typing was performed by serology with commercial kits for HLA class I and II (One Lambda, Canoga Park, Calif., USA). Results: The HLA-A23 frequency was 26.7% in the RAU patients, which was significantly higher than the 3.3% frequency in the patients with BD (p < 0.05). The HLA-A24 frequency was 33.3% in the RAU patient group, which was significantly higher (p < 0.05) than the frequency in the healthy subjects (6.7%). Significantly higher frequencies (46.7%) of HLA-A30 were found in the healthy subjects compared to the BD (13.3%) and RAU (3.3%) patients (p < 0.05 and p < 0.01, respectively). A higher frequency of HLA-B13 was observed in the RAU (23.3%) patients compared to the BD (0%) patients (p < 0.01). A decrease was observed in HLA-DR10 and HLA-DR17 in the RAU patients (p < 0.05), while a higher frequency of HLA-DR10 was observed in the BD patients compared to the RAU patients (p < 0.01). Conclusions: These results showed that RAU and BD were not in the same spectrum and the involvement of other genetic and/or environmental factors might be responsible for the development of these diseases and/or disease progression. Copyright (C) 2013 S. Karger AG, Basel
dc.identifier.doi10.1159/000348366
dc.identifier.eissn1423-0151
dc.identifier.issn1011-7571
dc.identifier.pubmed23485763
dc.identifier.urihttps://hdl.handle.net/11424/245376
dc.identifier.wosWOS:000324588400009
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofMEDICAL PRINCIPLES AND PRACTICE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRecurrent aphthous ulceration
dc.subjectBehcet's disease
dc.subjectHLA class I
dc.subjectHLA class II
dc.subjectAntigen
dc.subjectCLINICAL-FEATURES
dc.subjectORAL ULCERATION
dc.subjectASSOCIATION
dc.subjectHLA-B-ASTERISK-51
dc.subjectSTOMATITIS
dc.subjectALLELES
dc.subjectHAPLOTYPES
dc.subjectPHENOTYPES
dc.titleHLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behcet's Disease
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage468
oaire.citation.issue5
oaire.citation.startPage464
oaire.citation.titleMEDICAL PRINCIPLES AND PRACTICE
oaire.citation.volume22

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
564.58 KB
Format:
Adobe Portable Document Format